img

Global Oxcarbazepine Tablets Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oxcarbazepine Tablets Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Oxcarbazepine Tablets, sold under the brand name Trileptal among others, is a medication used to treat epilepsy and bipolar disorder.
Oxcarbazepine Tablets report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oxcarbazepine Tablets market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacy and Retail Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Oxcarbazepine Tablets industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Oxcarbazepine Tablets key manufacturers include Novartis (Trileptal), Supernus Pharmaceuticals (Oxtellar XR), Apotex, Sun Pharm, Jubilant Generics, Taro Pharmaceuticals, Stada Group, Mylan and Teva Pharmaceutical, etc. Novartis (Trileptal), Supernus Pharmaceuticals (Oxtellar XR), Apotex are top 3 players and held % sales share in total in 2022.
Oxcarbazepine Tablets can be divided into Tablets (150mg), Tablets (300mg) and Tablets (600mg),, etc. Tablets (150mg) is the mainstream product in the market, accounting for % sales share globally in 2022.
Oxcarbazepine Tablets is widely used in various fields, such as Hospital Pharmacy, Retail Pharmacy and Online Pharmacy,, etc. Hospital Pharmacy provides greatest supports to the Oxcarbazepine Tablets industry development. In 2022, global % sales of Oxcarbazepine Tablets went into Hospital Pharmacy filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oxcarbazepine Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novartis (Trileptal)
Supernus Pharmaceuticals (Oxtellar XR)
Apotex
Sun Pharm
Jubilant Generics
Taro Pharmaceuticals
Stada Group
Mylan
Teva Pharmaceutical
Hikma Pharmaceuticals
ANI Pharmaceuticals
Glenmark Pharmaceuticals
Roxane Laboratories
Nobelpharma
Jamp Pharma
Neuraxpharm
Orion Corporation
SihuanPharm
Humanwell Healthcare
Huikang Pharmaceutical
Nexgen pharma
Segment by Type
Tablets (150mg)
Tablets (300mg)
Tablets (600mg)

Segment by Application


Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Oxcarbazepine Tablets market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oxcarbazepine Tablets, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oxcarbazepine Tablets industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Oxcarbazepine Tablets in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oxcarbazepine Tablets introduction, etc. Oxcarbazepine Tablets Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Oxcarbazepine Tablets market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Oxcarbazepine Tablets Market Overview
1.1 Oxcarbazepine Tablets Product Overview
1.2 Oxcarbazepine Tablets Market Segment by Type
1.2.1 Tablets (150mg)
1.2.2 Tablets (300mg)
1.2.3 Tablets (600mg)
1.3 Global Oxcarbazepine Tablets Market Size by Type
1.3.1 Global Oxcarbazepine Tablets Market Size Overview by Type (2018-2034)
1.3.2 Global Oxcarbazepine Tablets Historic Market Size Review by Type (2018-2024)
1.3.3 Global Oxcarbazepine Tablets Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Oxcarbazepine Tablets Sales Breakdown by Type (2018-2024)
1.4.2 Europe Oxcarbazepine Tablets Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Oxcarbazepine Tablets Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Oxcarbazepine Tablets Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Oxcarbazepine Tablets Sales Breakdown by Type (2018-2024)
2 Global Oxcarbazepine Tablets Market Competition by Company
2.1 Global Top Players by Oxcarbazepine Tablets Sales (2018-2024)
2.2 Global Top Players by Oxcarbazepine Tablets Revenue (2018-2024)
2.3 Global Top Players by Oxcarbazepine Tablets Price (2018-2024)
2.4 Global Top Manufacturers Oxcarbazepine Tablets Manufacturing Base Distribution, Sales Area, Product Type
2.5 Oxcarbazepine Tablets Market Competitive Situation and Trends
2.5.1 Oxcarbazepine Tablets Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Oxcarbazepine Tablets Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oxcarbazepine Tablets as of 2022)
2.7 Date of Key Manufacturers Enter into Oxcarbazepine Tablets Market
2.8 Key Manufacturers Oxcarbazepine Tablets Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Oxcarbazepine Tablets Status and Outlook by Region
3.1 Global Oxcarbazepine Tablets Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Oxcarbazepine Tablets Historic Market Size by Region
3.2.1 Global Oxcarbazepine Tablets Sales in Volume by Region (2018-2024)
3.2.2 Global Oxcarbazepine Tablets Sales in Value by Region (2018-2024)
3.2.3 Global Oxcarbazepine Tablets Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Oxcarbazepine Tablets Forecasted Market Size by Region
3.3.1 Global Oxcarbazepine Tablets Sales in Volume by Region (2024-2034)
3.3.2 Global Oxcarbazepine Tablets Sales in Value by Region (2024-2034)
3.3.3 Global Oxcarbazepine Tablets Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Oxcarbazepine Tablets by Application
4.1 Oxcarbazepine Tablets Market Segment by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Online Pharmacy
4.2 Global Oxcarbazepine Tablets Market Size by Application
4.2.1 Global Oxcarbazepine Tablets Market Size Overview by Application (2018-2034)
4.2.2 Global Oxcarbazepine Tablets Historic Market Size Review by Application (2018-2024)
4.2.3 Global Oxcarbazepine Tablets Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Oxcarbazepine Tablets Sales Breakdown by Application (2018-2024)
4.3.2 Europe Oxcarbazepine Tablets Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Oxcarbazepine Tablets Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Oxcarbazepine Tablets Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Oxcarbazepine Tablets Sales Breakdown by Application (2018-2024)
5 North America Oxcarbazepine Tablets by Country
5.1 North America Oxcarbazepine Tablets Historic Market Size by Country
5.1.1 North America Oxcarbazepine Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Oxcarbazepine Tablets Sales in Volume by Country (2018-2024)
5.1.3 North America Oxcarbazepine Tablets Sales in Value by Country (2018-2024)
5.2 North America Oxcarbazepine Tablets Forecasted Market Size by Country
5.2.1 North America Oxcarbazepine Tablets Sales in Volume by Country (2024-2034)
5.2.2 North America Oxcarbazepine Tablets Sales in Value by Country (2024-2034)
6 Europe Oxcarbazepine Tablets by Country
6.1 Europe Oxcarbazepine Tablets Historic Market Size by Country
6.1.1 Europe Oxcarbazepine Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Oxcarbazepine Tablets Sales in Volume by Country (2018-2024)
6.1.3 Europe Oxcarbazepine Tablets Sales in Value by Country (2018-2024)
6.2 Europe Oxcarbazepine Tablets Forecasted Market Size by Country
6.2.1 Europe Oxcarbazepine Tablets Sales in Volume by Country (2024-2034)
6.2.2 Europe Oxcarbazepine Tablets Sales in Value by Country (2024-2034)
7 Asia-Pacific Oxcarbazepine Tablets by Region
7.1 Asia-Pacific Oxcarbazepine Tablets Historic Market Size by Region
7.1.1 Asia-Pacific Oxcarbazepine Tablets Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Oxcarbazepine Tablets Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Oxcarbazepine Tablets Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Oxcarbazepine Tablets Forecasted Market Size by Region
7.2.1 Asia-Pacific Oxcarbazepine Tablets Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Oxcarbazepine Tablets Sales in Value by Region (2024-2034)
8 Latin America Oxcarbazepine Tablets by Country
8.1 Latin America Oxcarbazepine Tablets Historic Market Size by Country
8.1.1 Latin America Oxcarbazepine Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Oxcarbazepine Tablets Sales in Volume by Country (2018-2024)
8.1.3 Latin America Oxcarbazepine Tablets Sales in Value by Country (2018-2024)
8.2 Latin America Oxcarbazepine Tablets Forecasted Market Size by Country
8.2.1 Latin America Oxcarbazepine Tablets Sales in Volume by Country (2024-2034)
8.2.2 Latin America Oxcarbazepine Tablets Sales in Value by Country (2024-2034)
9 Middle East and Africa Oxcarbazepine Tablets by Country
9.1 Middle East and Africa Oxcarbazepine Tablets Historic Market Size by Country
9.1.1 Middle East and Africa Oxcarbazepine Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Oxcarbazepine Tablets Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Oxcarbazepine Tablets Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Oxcarbazepine Tablets Forecasted Market Size by Country
9.2.1 Middle East and Africa Oxcarbazepine Tablets Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Oxcarbazepine Tablets Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Novartis (Trileptal)
10.1.1 Novartis (Trileptal) Company Information
10.1.2 Novartis (Trileptal) Introduction and Business Overview
10.1.3 Novartis (Trileptal) Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Novartis (Trileptal) Oxcarbazepine Tablets Products Offered
10.1.5 Novartis (Trileptal) Recent Development
10.2 Supernus Pharmaceuticals (Oxtellar XR)
10.2.1 Supernus Pharmaceuticals (Oxtellar XR) Company Information
10.2.2 Supernus Pharmaceuticals (Oxtellar XR) Introduction and Business Overview
10.2.3 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Tablets Products Offered
10.2.5 Supernus Pharmaceuticals (Oxtellar XR) Recent Development
10.3 Apotex
10.3.1 Apotex Company Information
10.3.2 Apotex Introduction and Business Overview
10.3.3 Apotex Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Apotex Oxcarbazepine Tablets Products Offered
10.3.5 Apotex Recent Development
10.4 Sun Pharm
10.4.1 Sun Pharm Company Information
10.4.2 Sun Pharm Introduction and Business Overview
10.4.3 Sun Pharm Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Sun Pharm Oxcarbazepine Tablets Products Offered
10.4.5 Sun Pharm Recent Development
10.5 Jubilant Generics
10.5.1 Jubilant Generics Company Information
10.5.2 Jubilant Generics Introduction and Business Overview
10.5.3 Jubilant Generics Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Jubilant Generics Oxcarbazepine Tablets Products Offered
10.5.5 Jubilant Generics Recent Development
10.6 Taro Pharmaceuticals
10.6.1 Taro Pharmaceuticals Company Information
10.6.2 Taro Pharmaceuticals Introduction and Business Overview
10.6.3 Taro Pharmaceuticals Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Taro Pharmaceuticals Oxcarbazepine Tablets Products Offered
10.6.5 Taro Pharmaceuticals Recent Development
10.7 Stada Group
10.7.1 Stada Group Company Information
10.7.2 Stada Group Introduction and Business Overview
10.7.3 Stada Group Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Stada Group Oxcarbazepine Tablets Products Offered
10.7.5 Stada Group Recent Development
10.8 Mylan
10.8.1 Mylan Company Information
10.8.2 Mylan Introduction and Business Overview
10.8.3 Mylan Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Mylan Oxcarbazepine Tablets Products Offered
10.8.5 Mylan Recent Development
10.9 Teva Pharmaceutical
10.9.1 Teva Pharmaceutical Company Information
10.9.2 Teva Pharmaceutical Introduction and Business Overview
10.9.3 Teva Pharmaceutical Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Teva Pharmaceutical Oxcarbazepine Tablets Products Offered
10.9.5 Teva Pharmaceutical Recent Development
10.10 Hikma Pharmaceuticals
10.10.1 Hikma Pharmaceuticals Company Information
10.10.2 Hikma Pharmaceuticals Introduction and Business Overview
10.10.3 Hikma Pharmaceuticals Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Hikma Pharmaceuticals Oxcarbazepine Tablets Products Offered
10.10.5 Hikma Pharmaceuticals Recent Development
10.11 ANI Pharmaceuticals
10.11.1 ANI Pharmaceuticals Company Information
10.11.2 ANI Pharmaceuticals Introduction and Business Overview
10.11.3 ANI Pharmaceuticals Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.11.4 ANI Pharmaceuticals Oxcarbazepine Tablets Products Offered
10.11.5 ANI Pharmaceuticals Recent Development
10.12 Glenmark Pharmaceuticals
10.12.1 Glenmark Pharmaceuticals Company Information
10.12.2 Glenmark Pharmaceuticals Introduction and Business Overview
10.12.3 Glenmark Pharmaceuticals Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Glenmark Pharmaceuticals Oxcarbazepine Tablets Products Offered
10.12.5 Glenmark Pharmaceuticals Recent Development
10.13 Roxane Laboratories
10.13.1 Roxane Laboratories Company Information
10.13.2 Roxane Laboratories Introduction and Business Overview
10.13.3 Roxane Laboratories Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Roxane Laboratories Oxcarbazepine Tablets Products Offered
10.13.5 Roxane Laboratories Recent Development
10.14 Nobelpharma
10.14.1 Nobelpharma Company Information
10.14.2 Nobelpharma Introduction and Business Overview
10.14.3 Nobelpharma Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Nobelpharma Oxcarbazepine Tablets Products Offered
10.14.5 Nobelpharma Recent Development
10.15 Jamp Pharma
10.15.1 Jamp Pharma Company Information
10.15.2 Jamp Pharma Introduction and Business Overview
10.15.3 Jamp Pharma Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Jamp Pharma Oxcarbazepine Tablets Products Offered
10.15.5 Jamp Pharma Recent Development
10.16 Neuraxpharm
10.16.1 Neuraxpharm Company Information
10.16.2 Neuraxpharm Introduction and Business Overview
10.16.3 Neuraxpharm Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Neuraxpharm Oxcarbazepine Tablets Products Offered
10.16.5 Neuraxpharm Recent Development
10.17 Orion Corporation
10.17.1 Orion Corporation Company Information
10.17.2 Orion Corporation Introduction and Business Overview
10.17.3 Orion Corporation Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Orion Corporation Oxcarbazepine Tablets Products Offered
10.17.5 Orion Corporation Recent Development
10.18 SihuanPharm
10.18.1 SihuanPharm Company Information
10.18.2 SihuanPharm Introduction and Business Overview
10.18.3 SihuanPharm Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.18.4 SihuanPharm Oxcarbazepine Tablets Products Offered
10.18.5 SihuanPharm Recent Development
10.19 Humanwell Healthcare
10.19.1 Humanwell Healthcare Company Information
10.19.2 Humanwell Healthcare Introduction and Business Overview
10.19.3 Humanwell Healthcare Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Humanwell Healthcare Oxcarbazepine Tablets Products Offered
10.19.5 Humanwell Healthcare Recent Development
10.20 Huikang Pharmaceutical
10.20.1 Huikang Pharmaceutical Company Information
10.20.2 Huikang Pharmaceutical Introduction and Business Overview
10.20.3 Huikang Pharmaceutical Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Huikang Pharmaceutical Oxcarbazepine Tablets Products Offered
10.20.5 Huikang Pharmaceutical Recent Development
10.21 Nexgen pharma
10.21.1 Nexgen pharma Company Information
10.21.2 Nexgen pharma Introduction and Business Overview
10.21.3 Nexgen pharma Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Nexgen pharma Oxcarbazepine Tablets Products Offered
10.21.5 Nexgen pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Oxcarbazepine Tablets Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Oxcarbazepine Tablets Industrial Chain Analysis
11.4 Oxcarbazepine Tablets Market Dynamics
11.4.1 Oxcarbazepine Tablets Industry Trends
11.4.2 Oxcarbazepine Tablets Market Drivers
11.4.3 Oxcarbazepine Tablets Market Challenges
11.4.4 Oxcarbazepine Tablets Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Oxcarbazepine Tablets Distributors
12.3 Oxcarbazepine Tablets Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Tablets (150mg)
Table 2. Major Company of Tablets (300mg)
Table 3. Major Company of Tablets (600mg)
Table 4. Global Oxcarbazepine Tablets Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Oxcarbazepine Tablets Sales by Type (2018-2024) & (M Unit)
Table 6. Global Oxcarbazepine Tablets Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Oxcarbazepine Tablets Sales by Type (2018-2024) & (US& Million)
Table 8. Global Oxcarbazepine Tablets Market Share in Value by Type (2018-2024)
Table 9. Global Oxcarbazepine Tablets Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Oxcarbazepine Tablets Sales by Type (2024-2034) & (M Unit)
Table 11. Global Oxcarbazepine Tablets Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Oxcarbazepine Tablets Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Oxcarbazepine Tablets Sales Market Share in Value by Type (2024-2034)
Table 14. Global Oxcarbazepine Tablets Price by Type (2024-2034) & (USD/Unit)
Table 15. North America Oxcarbazepine Tablets Sales by Type (2018-2024) & (M Unit)
Table 16. North America Oxcarbazepine Tablets Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Oxcarbazepine Tablets Sales (M Unit) by Type (2018-2024)
Table 18. Europe Oxcarbazepine Tablets Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Oxcarbazepine Tablets Sales (M Unit) by Type (2018-2024)
Table 20. Asia-Pacific Oxcarbazepine Tablets Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Oxcarbazepine Tablets Sales (M Unit) by Type (2018-2024)
Table 22. Latin America Oxcarbazepine Tablets Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Oxcarbazepine Tablets Sales (M Unit) by Type (2018-2024)
Table 24. Middle East and Africa Oxcarbazepine Tablets Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Oxcarbazepine Tablets Sales by Company (2018-2024) & (M Unit)
Table 26. Global Oxcarbazepine Tablets Sales Share by Company (2018-2024)
Table 27. Global Oxcarbazepine Tablets Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Oxcarbazepine Tablets Revenue Share by Company (2018-2024)
Table 29. Global Market Oxcarbazepine Tablets Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Oxcarbazepine Tablets Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Oxcarbazepine Tablets Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oxcarbazepine Tablets as of 2022)
Table 33. Date of Key Manufacturers Enter into Oxcarbazepine Tablets Market
Table 34. Key Manufacturers Oxcarbazepine Tablets Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Oxcarbazepine Tablets Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Oxcarbazepine Tablets Sales by Region (2018-2024) & (M Unit)
Table 38. Global Oxcarbazepine Tablets Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Oxcarbazepine Tablets Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Oxcarbazepine Tablets Sales Market Share in Value by Region (2018-2024)
Table 41. Global Oxcarbazepine Tablets Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Oxcarbazepine Tablets Sales by Region (2024-2034) & (M Unit)
Table 43. Global Oxcarbazepine Tablets Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Oxcarbazepine Tablets Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Oxcarbazepine Tablets Sales Market Share in Value by Region (2024-2034)
Table 46. Global Oxcarbazepine Tablets Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 47. Global Oxcarbazepine Tablets Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Oxcarbazepine Tablets Sales by Application (2018-2024) & (M Unit)
Table 49. Global Oxcarbazepine Tablets Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Oxcarbazepine Tablets Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Oxcarbazepine Tablets Sales Market Share in Value by Application (2018-2024)
Table 52. Global Oxcarbazepine Tablets Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Oxcarbazepine Tablets Sales by Application (2024-2034) & (M Unit)
Table 54. Global Oxcarbazepine Tablets Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Oxcarbazepine Tablets Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Oxcarbazepine Tablets Sales Market Share in Value by Application (2024-2034)
Table 57. Global Oxcarbazepine Tablets Price by Application (2024-2034) & (USD/Unit)
Table 58. North America Oxcarbazepine Tablets Sales by Application (2018-2024) (M Unit)
Table 59. North America Oxcarbazepine Tablets Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Oxcarbazepine Tablets Sales by Application (2018-2024) (M Unit)
Table 61. Europe Oxcarbazepine Tablets Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Oxcarbazepine Tablets Sales by Application (2018-2024) (M Unit)
Table 63. Asia-Pacific Oxcarbazepine Tablets Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Oxcarbazepine Tablets Sales by Application (2018-2024) (M Unit)
Table 65. Latin America Oxcarbazepine Tablets Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Oxcarbazepine Tablets Sales by Application (2018-2024) (M Unit)
Table 67. Middle East and Africa Oxcarbazepine Tablets Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Oxcarbazepine Tablets Sales by Country (2018-2024) & (M Unit)
Table 69. North America Oxcarbazepine Tablets Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Oxcarbazepine Tablets Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Oxcarbazepine Tablets Sales Market Share in Value by Country (2018-2024)
Table 72. North America Oxcarbazepine Tablets Sales by Country (2024-2034) & (M Unit)
Table 73. North America Oxcarbazepine Tablets Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Oxcarbazepine Tablets Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Oxcarbazepine Tablets Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Oxcarbazepine Tablets Sales by Country (2018-2024) & (M Unit)
Table 77. Europe Oxcarbazepine Tablets Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Oxcarbazepine Tablets Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Oxcarbazepine Tablets Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Oxcarbazepine Tablets Sales by Country (2024-2034) & (M Unit)
Table 81. Europe Oxcarbazepine Tablets Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Oxcarbazepine Tablets Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Oxcarbazepine Tablets Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Oxcarbazepine Tablets Sales by Region (2018-2024) & (M Unit)
Table 85. Asia-Pacific Oxcarbazepine Tablets Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Oxcarbazepine Tablets Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Oxcarbazepine Tablets Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Oxcarbazepine Tablets Sales by Region (2024-2034) & (M Unit)
Table 89. Asia-Pacific Oxcarbazepine Tablets Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Oxcarbazepine Tablets Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Oxcarbazepine Tablets Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Oxcarbazepine Tablets Sales by Country (2018-2024) & (M Unit)
Table 93. Latin America Oxcarbazepine Tablets Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Oxcarbazepine Tablets Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Oxcarbazepine Tablets Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Oxcarbazepine Tablets Sales by Country (2024-2034) & (M Unit)
Table 97. Latin America Oxcarbazepine Tablets Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Oxcarbazepine Tablets Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Oxcarbazepine Tablets Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Oxcarbazepine Tablets Sales by Country (2018-2024) & (M Unit)
Table 101. Middle East and Africa Oxcarbazepine Tablets Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Oxcarbazepine Tablets Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Oxcarbazepine Tablets Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Oxcarbazepine Tablets Sales by Country (2024-2034) & (M Unit)
Table 105. Middle East and Africa Oxcarbazepine Tablets Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Oxcarbazepine Tablets Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Oxcarbazepine Tablets Sales Market Share in Value by Country (2024-2034)
Table 108. Novartis (Trileptal) Company Information
Table 109. Novartis (Trileptal) Introduction and Business Overview
Table 110. Novartis (Trileptal) Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Novartis (Trileptal) Oxcarbazepine Tablets Product
Table 112. Novartis (Trileptal) Recent Development
Table 113. Supernus Pharmaceuticals (Oxtellar XR) Company Information
Table 114. Supernus Pharmaceuticals (Oxtellar XR) Introduction and Business Overview
Table 115. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Tablets Product
Table 117. Supernus Pharmaceuticals (Oxtellar XR) Recent Development
Table 118. Apotex Company Information
Table 119. Apotex Introduction and Business Overview
Table 120. Apotex Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Apotex Oxcarbazepine Tablets Product
Table 122. Apotex Recent Development
Table 123. Sun Pharm Company Information
Table 124. Sun Pharm Introduction and Business Overview
Table 125. Sun Pharm Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Sun Pharm Oxcarbazepine Tablets Product
Table 127. Sun Pharm Recent Development
Table 128. Jubilant Generics Company Information
Table 129. Jubilant Generics Introduction and Business Overview
Table 130. Jubilant Generics Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Jubilant Generics Oxcarbazepine Tablets Product
Table 132. Jubilant Generics Recent Development
Table 133. Taro Pharmaceuticals Company Information
Table 134. Taro Pharmaceuticals Introduction and Business Overview
Table 135. Taro Pharmaceuticals Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Taro Pharmaceuticals Oxcarbazepine Tablets Product
Table 137. Taro Pharmaceuticals Recent Development
Table 138. Stada Group Company Information
Table 139. Stada Group Introduction and Business Overview
Table 140. Stada Group Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Stada Group Oxcarbazepine Tablets Product
Table 142. Stada Group Recent Development
Table 143. Mylan Company Information
Table 144. Mylan Introduction and Business Overview
Table 145. Mylan Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Mylan Oxcarbazepine Tablets Product
Table 147. Mylan Recent Development
Table 148. Teva Pharmaceutical Company Information
Table 149. Teva Pharmaceutical Introduction and Business Overview
Table 150. Teva Pharmaceutical Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Teva Pharmaceutical Oxcarbazepine Tablets Product
Table 152. Teva Pharmaceutical Recent Development
Table 153. Hikma Pharmaceuticals Company Information
Table 154. Hikma Pharmaceuticals Introduction and Business Overview
Table 155. Hikma Pharmaceuticals Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Hikma Pharmaceuticals Oxcarbazepine Tablets Product
Table 157. Hikma Pharmaceuticals Recent Development
Table 158. ANI Pharmaceuticals Company Information
Table 159. ANI Pharmaceuticals Introduction and Business Overview
Table 160. ANI Pharmaceuticals Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. ANI Pharmaceuticals Oxcarbazepine Tablets Product
Table 162. ANI Pharmaceuticals Recent Development
Table 163. Glenmark Pharmaceuticals Company Information
Table 164. Glenmark Pharmaceuticals Introduction and Business Overview
Table 165. Glenmark Pharmaceuticals Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. Glenmark Pharmaceuticals Oxcarbazepine Tablets Product
Table 167. Glenmark Pharmaceuticals Recent Development
Table 168. Roxane Laboratories Company Information
Table 169. Roxane Laboratories Introduction and Business Overview
Table 170. Roxane Laboratories Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 171. Roxane Laboratories Oxcarbazepine Tablets Product
Table 172. Roxane Laboratories Recent Development
Table 173. Nobelpharma Company Information
Table 174. Nobelpharma Introduction and Business Overview
Table 175. Nobelpharma Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 176. Nobelpharma Oxcarbazepine Tablets Product
Table 177. Nobelpharma Recent Development
Table 178. Jamp Pharma Company Information
Table 179. Jamp Pharma Introduction and Business Overview
Table 180. Jamp Pharma Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 181. Jamp Pharma Oxcarbazepine Tablets Product
Table 182. Jamp Pharma Recent Development
Table 183. Neuraxpharm Company Information
Table 184. Neuraxpharm Introduction and Business Overview
Table 185. Neuraxpharm Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 186. Neuraxpharm Oxcarbazepine Tablets Product
Table 187. Neuraxpharm Recent Development
Table 188. Orion Corporation Company Information
Table 189. Orion Corporation Introduction and Business Overview
Table 190. Orion Corporation Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 191. Orion Corporation Oxcarbazepine Tablets Product
Table 192. Orion Corporation Recent Development
Table 193. SihuanPharm Company Information
Table 194. SihuanPharm Introduction and Business Overview
Table 195. SihuanPharm Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 196. SihuanPharm Oxcarbazepine Tablets Product
Table 197. SihuanPharm Recent Development
Table 198. Humanwell Healthcare Company Information
Table 199. Humanwell Healthcare Introduction and Business Overview
Table 200. Humanwell Healthcare Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 201. Humanwell Healthcare Oxcarbazepine Tablets Product
Table 202. Humanwell Healthcare Recent Development
Table 203. Huikang Pharmaceutical Company Information
Table 204. Huikang Pharmaceutical Introduction and Business Overview
Table 205. Huikang Pharmaceutical Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 206. Huikang Pharmaceutical Oxcarbazepine Tablets Product
Table 207. Huikang Pharmaceutical Recent Development
Table 208. Nexgen pharma Company Information
Table 209. Nexgen pharma Introduction and Business Overview
Table 210. Nexgen pharma Oxcarbazepine Tablets Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 211. Nexgen pharma Oxcarbazepine Tablets Product
Table 212. Nexgen pharma Recent Development
Table 213. Key Raw Materials Lists
Table 214. Raw Materials Key Suppliers Lists
Table 215. Oxcarbazepine Tablets Market Trends
Table 216. Oxcarbazepine Tablets Market Drivers
Table 217. Oxcarbazepine Tablets Market Challenges
Table 218. Oxcarbazepine Tablets Market Restraints
Table 219. Oxcarbazepine Tablets Distributors List
Table 220. Oxcarbazepine Tablets Downstream Customers
Table 221. Research Programs/Design for This Report
Table 222. Key Data Information from Secondary Sources
Table 223. Key Data Information from Primary Sources
List of Figures
Figure 1. Oxcarbazepine Tablets Product Picture
Figure 2. Global Oxcarbazepine Tablets Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Oxcarbazepine Tablets Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Oxcarbazepine Tablets Sales Status and Outlook (2018-2034) & (M Unit)
Figure 5. Product Picture of Tablets (150mg)
Figure 6. Global Tablets (150mg) Sales YoY Growth (2018-2034) & (M Unit)
Figure 7. Product Picture of Tablets (300mg)
Figure 8. Global Tablets (300mg) Sales YoY Growth (2018-2034) & (M Unit)
Figure 9. Product Picture of Tablets (600mg)
Figure 10. Global Tablets (600mg) Sales YoY Growth (2018-2034) & (M Unit)
Figure 11. Global Oxcarbazepine Tablets Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Oxcarbazepine Tablets Sales Market Share by Type in 2022 & 2034
Figure 13. North America Oxcarbazepine Tablets Sales Market Share in Volume by Type in 2022
Figure 14. North America Oxcarbazepine Tablets Sales Market Share in Value by Type in 2022
Figure 15. Europe Oxcarbazepine Tablets Sales Market Share in Volume by Type in 2022
Figure 16. Europe Oxcarbazepine Tablets Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Oxcarbazepine Tablets Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Oxcarbazepine Tablets Sales Market Share in Value by Type in 2022
Figure 19. Latin America Oxcarbazepine Tablets Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Oxcarbazepine Tablets Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Oxcarbazepine Tablets Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Oxcarbazepine Tablets Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Oxcarbazepine Tablets Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Oxcarbazepine Tablets Revenue in 2022
Figure 25. Oxcarbazepine Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospital Pharmacy
Figure 27. Global Hospital Pharmacy Sales YoY Growth (2018-2034) & (M Unit)
Figure 28. Product Picture of Retail Pharmacy
Figure 29. Global Retail Pharmacy Sales YoY Growth (2018-2034) & (M Unit)
Figure 30. Product Picture of Online Pharmacy
Figure 31. Global Online Pharmacy Sales YoY Growth (2018-2034) & (M Unit)
Figure 32. Global Oxcarbazepine Tablets Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Oxcarbazepine Tablets Sales Market Share by Application in 2022 & 2034
Figure 34. North America Oxcarbazepine Tablets Sales Market Share in Volume by Application in 2022
Figure 35. North America Oxcarbazepine Tablets Sales Market Share in Value by Application in 2022
Figure 36. Europe Oxcarbazepine Tablets Sales Market Share in Volume by Application in 2022
Figure 37. Europe Oxcarbazepine Tablets Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Oxcarbazepine Tablets Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Oxcarbazepine Tablets Sales Market Share in Value by Application in 2022
Figure 40. Latin America Oxcarbazepine Tablets Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Oxcarbazepine Tablets Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Oxcarbazepine Tablets Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Oxcarbazepine Tablets Manufacturing Cost Structure
Figure 45. Oxcarbazepine Tablets Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed